🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Part I: 12 subjects will receive an open-label 500 µl subcutaneous injecti...
Status
Completed
Location
University Hospital Tuebingen
Start Date
2020-11-27
Trial ID
NCT04546841
Treatments Being Tested
The aim of this study is to evaluate the efficiency along with safety and t...
Status
Completed
Location
University Hospital Tuebingen
Start Date
2020-12-23
Trial ID
NCT04688385
Treatments Being Tested
The aim of this Phase I study is to evaluate the immunogenicity along with ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-05-02
Trial ID
NCT06252584
Treatments Being Tested
Newly diagnosed HLA-A2-positive MGMT-methylated glioblastoma patients will ...
Status
Completed
Location
University Hospital Tübingen
Start Date
2021-05-03
Trial ID
NCT04842513
Treatments Being Tested